NEMLIT level S medicines in Tanzania: what zonal, special and national hospitals can stock and who can prescribe them
Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) lists 286 medicines at level S, meaning they should be available at zonal, special and national hospitals. Level S medicines may be prescribed by specialists. None of them is on the DukaDawa pharmacy network yet.
Last updated
Which medicines can zonal, special and national hospitals stock in Tanzania?
The NEMLIT (7th edition, 2026) lists 286 medicines at level S (zonal, special and national hospitals), in 63 categories, most in Antineoplastics, Immunosuppressives and Immunomodulators. Zonal, special and national hospitals may also stock medicines listed at levels A, B, C and D.
By category
- Antineoplastics, Immunosuppressives and Immunomodulators (89)
- Reserve Group Antibiotics (14)
- Antihypertensive Medicines (12)
- Medicines used in Psychotic Disorders (10)
- Medicines used in Depressive disorders (9)
- Injectable Medicines and Other Pre-Medication (8)
- Medicines for Notifiable and Neglected Tropical Diseases (8)
- Medicines Used in Heart Failure (7)
- Muscle Relaxants and Cholinesterase Inhibitors (6)
- Other Ocular Preparations (6)
- Anti-infective Agents (4)
- Antianginal Medicines (4)
- Antiarrhythmic Medicines (4)
- Diuretics (4)
- Medicines Affecting Skin differentiation and Proliferation (4)
- Medicines Used for Diabetes and Related Disorders (4)
- Non-opioids and Non-steroidal Anti-inflammatory Medicines (NSAIMs) (4)
- Ovulation Inducers (4)
- Thrombolytics (4)
- Ant parkinsonism Medicines and Anti prolactinoma (3)
- Anti- Platelet Medicines (3)
- Anticonvulsants and Antiepileptics (3)
- Antidotes (Specific) (3)
- Antifungal Medicines (3)
- Blood Coagulation Factors (3)
- Drugs affecting Intestinal Secretion and Antispasmodics (3)
- Medicines Affecting Coagulation (3)
- Medicines Used for Disorders due to Psychoactive Substance use (3)
- Miotics and Antiglaucoma (3)
- Muscle Relaxants (Peripherally-Acting) and Cholinesterase Inhibitors (3)
- Posterior Pituitary Hormones and Analogues (3)
- Vitamins/Minerals (3)
- Adrenal Hormones and Synthetic Substitutes (2)
- Anti-asthmatics (2)
- Anti-inflammatory and Anti-pruritic Medicines (2)
- Antiulcer Medicines (2)
- Bisphosphonate (Bone resorption inhibitor) (2)
- Human Immunoglobulins (2)
- Medicines for Overactive Bladder (2)
- Medicines for Treatment of Acute Attack (2)
- Nasal Preparations (2)
- Phosphate Binders (2)
- Watch Group Antibiotics (2)
- Anti- anaemia Medicines (1)
- Anti-allergies and Medicines Used in Anaphylaxis (1)
- Anti-Haemorrhoids (1)
- Anti-Herpes Medicines (1)
- Antifibrotic / Respiratory (1)
- Antipneumocystosis and ant toxoplasmosis medicines (1)
- Cathartics (1)
- Dialysis Solution and Other Related Medicines (1)
- Digestive/Pancreatic enzyme preparations (1)
- For Immunization (1)
- Gonadotropin-Releasing Hormone (GnRH) Analogues / Agonists (1)
- Inhalational Medicines (1)
- Lipid Lowering Medicines (1)
- Medicines for Hepatitis-B (1)
- Medicines in Bipolar Disorders (1)
- Mydriatics and Anti-vascular Endothelial (1)
- Oestrogens (1)
- Opioid Analgesics/Antagonists (1)
- Plasma Substitutes (1)
- Progesterone (1)
| Medicine | Level | Category | Listed forms | Page |
|---|---|---|---|---|
| 3,4-diaminopyridine | S | Muscle Relaxants (Peripherally-Acting) and Cholinesterase Inhibitors | Tablet: 10mg | p. 24 |
| 5 –Fluoro Uracil | S | Other Ocular Preparations | Eye drops: 1% | p. 25 |
| 5-fluorouracil | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 250mg; 500mg; 000mg; | p. 12 |
| 6-Mercaptopurine | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 50 mg oral suspension: 20 mg/mL | p. 12 |
| Abiraterone acetate | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 250mg; 500 mg | p. 12 |
| Acetylcholine | S | Miotics and Antiglaucoma | Injection; 10 mg/ml | p. 25 |
| Adalimumab | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection 40mg/0.8mL, 10mg / 0.2mL | p. 14 |
| Adapalene | S | Medicines Affecting Skin differentiation and Proliferation | Gel / Cream / Lotion: 0.1% and 0.3% | p. 21 |
| Adenosine | S | Antiarrhythmic Medicines | Injection: 3mg/ml | p. 18 |
| Aflibercept | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 2mg/0.05ml | p. 13 |
| Albumin | S | Plasma Substitutes | Solution for intravenous infusion: 5%; 20%, 25% | p. 18 |
| Alteplase | S | Thrombolytics | Powder for injection: 50mg, 100mg vial | p. 20 |
| Amikacin | S | Reserve Group Antibiotics | Injection 250mg/mL (as sulfate) | p. 8 |
| Amiodarone | S | Antiarrhythmic Medicines | Injection: 50 mg/mL (hydrochloride) in 3 mL ampoule. Tablet: 100 mg; 200 mg; 400 mg (hydrochloride). | p. 18 |
| Amphotericin B Deoxycholate | S | Antifungal Medicines | Powder for injection 5mg/ml | p. 9 |
| Anastrozole | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 1mg | p. 12 |
| Antithymocyte globulin (ATG) (rabbit) | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 25mg/mL in 5mL | p. 12 |
| Apixaban | S | Medicines Affecting Coagulation | Tablet 2.5mg, 5mg | p. 17 |
| Aripiprazole | S | Medicines used in Psychotic Disorders | Tablet: 5mg, 10mg, 15mg, 20mg, 30 mg | p. 26 |
| Atezolizumab | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 60 mg/ml; 125 mg/ml | p. 12 |
| Atomoxetine | S | Medicines used in Depressive disorders | Tablet: 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, and 100 mg | p. 27 |
| Atracurium | S | Muscle Relaxants and Cholinesterase Inhibitors | Injection 50mg/5mL | p. 4 |
| Axitinib | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet 1mg, 3mg,5 mg | p. 14 |
| Azacitidine | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 25mg/mL (With control) | p. 12 |
| Azacitidine | S | Antineoplastics, Immunosuppressives and Immunomodulators | Powder for injection: 100 mg single-dose vial. Tablets: 200 mg; 300 mg | p. 13 |
| Azathioprine | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet 50mg, 75mg, 100mg | p. 12 |
| Baclofen | S | Muscle Relaxants and Cholinesterase Inhibitors | Intrathecal injection: 500 micrograms/mL in ampoule. Oral liquid: 10 mg/5ml. Tablet: 10 mg. | p. 4 |
| Basiliximab | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection 20mg | p. 12 |
| Bedaquiline | S | Reserve Group Antibiotics | Tablet 100 mg | p. 9 |
| Bevacizumab | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 25mg/ml | p. 12 |
| Bicalutamide | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet 150mg, 50mg | p. 13 |
| Bisoprolol | S | Antianginal Medicines | Tablet: 1.25 mg; 5 mg; 10mg | p. 18 |
| Bleomycin | S | Antineoplastics, Immunosuppressives and Immunomodulators | Powder for injection: 15 IU (as sulfate) in vial | p. 13 |
| Bortezomib | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 3.5mg/vial | p. 13 |
| Bosentan | S | Antihypertensive Medicines | Tablet: 62.5 mg, 125mg | p. 19 |
| Botulinum toxin A injection | S | Muscle Relaxants and Cholinesterase Inhibitors | Powder for injection: 50 units, 100 units and 200 units | p. 4 |
| Brinzolamide | S | Miotics and Antiglaucoma | Eye Drops: 1% | p. 25 |
| Buprenorphine | S | Medicines Used for Disorders due to Psychoactive Substance use | Sublingual Tablets: 2 mg | p. 27 |
| Bupropion | S | Medicines Used for Disorders due to Psychoactive Substance use | Tablet: 150 mg; 300 mg; 450 mg | p. 27 |
| Cabergoline | S | Ant parkinsonism Medicines and Anti prolactinoma | Tablet 0.5mg, 1mg | p. 16 |
| Cabozantinib | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 20 mg: 40 mg: 60 mg | p. 14 |
| Calcium Acetate | S | Phosphate Binders | Oral Capsules: 667 mg (provides 169 mg of elemental calcium) Oral Tablets: 667 mg Oral Solution: 667 mg/5 mL (provides 169 mg of elemental calcium per 5 mL | p. 29 |
| Candesartan | S | Antihypertensive Medicines | Tablet: 8 mg, 16mg | p. 18 |
| Candesartan | S | Medicines Used in Heart Failure | Tablet: 8mg, 16mg Tablet: in fixed dose combination | p. 19 |
| Capecitabine | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet 500mg | p. 13 |
| Carboplatin | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 10mg/mL | p. 13 |
| Cefixime | S | Watch Group Antibiotics | Capsule 200 mg, 400 mg (Level A for STI and Typhoid only) | p. 8 |
| Cetrorelix | S | Ovulation Inducers | Powder for Injection: 0.25mg/ml, 3mg/ml (as acetate) | p. 15 |
| Cetuximab | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 2 mg/mL | p. 13 |
| Chlorambucil | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 2mg | p. 13 |
| Chlorhexidine | S | Anti-infective Agents | Eye Drops: 0.2% | p. 24 |
| Chlorthalidone | S | Diuretics | Tablet: 12.5mg; 25mg; 50 mg; 100 mg | p. 19 |
| Cholestyramine | A, S | Drugs affecting Intestinal Secretion and Antispasmodics | Powder 4g per Sachet Tablet 10mg | p. 22 |
| Cilostazol | S | Anti- Platelet Medicines | Tablet: 50 mg; 100 mg | p. 20 |
| Cisplatin | S | Antineoplastics, Immunosuppressives and Immunomodulators | Powder for injection: 50 mg; 10mg in vial. | p. 13 |
| Clindamycin | S | Reserve Group Antibiotics | Capsule 150 mg (as hydrochloride); Injection (as phosphate) 150 mg/mL in 2 mL ampoule | p. 8 |
| Clonazepam | D, S | Anticonvulsants and Antiepileptics | Tablet 0.5mg, 2mg Injection: 1mg/ml | p. 6 |
| Clonidine | S | Injectable Medicines and Other Pre-Medication | Injection 500mcg/mL | p. 3 |
| Clonidine | S | Antihypertensive Medicines | Injection 500mcg/mL; Tablet 0.1 mg, 0.2 mg and 0.3 mg | p. 18 |
| Clozapine | S | Medicines used in Psychotic Disorders | Tablet 25mg, 100mg, 200mg | p. 26 |
| Coagulation Factor IX | S | Blood Coagulation Factors | Powder for injection 250IU, 500 IU, 1000 IU, 2000 IU, 3000 IU per vial | p. 18 |
| Coagulation Factor VIII | S | Blood Coagulation Factors | Powder for injection 250IU, 500 IU, 1000 IU, 1500 IU, 2000 IU, 3000 IU per vial | p. 18 |
| Colistin | S | Reserve Group Antibiotics | Powder for injection: 1 million IU (as colistemethate sodium) (equivalent to 34 mg colistin base activity) in vial. Powder for nebulizer solution: 1–2MIU via nebulizer | p. 9 |
| Crizotinib | S | Antineoplastics, Immunosuppressives and Immunomodulators | Capsule: 200mg, 250mg | p. 14 |
| Cyclophosphamide | S | Antineoplastics, Immunosuppressives and Immunomodulators | Powder for injection: 500 mg; 1 g; 2 g in vial. Tablet/capsule: 25 mg; 50 mg. | p. 13 |
| Cycloserine | S | Reserve Group Antibiotics | Tablet 250 mg | p. 9 |
| Cyclosporine | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 50 mg/mL in 1-mL ampoule; Capsule: 25 mg; 50mg; 100mg | p. 13 |
| Cyclosporine | S | Other Ocular Preparations | Eye drops: 0.05% | p. 25 |
| Cytarabine | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection 100mg/ml | p. 13 |
| Cytidine + Uridine | S | Vitamins/Minerals | Tablet or capsule containing Cytidine 5mg + Uridine 3mg | p. 29 |
| Dabrafenib | S | Antineoplastics, Immunosuppressives and Immunomodulators | Capsule: 50mg, 75mg, 150mg | p. 14 |
| Dacarbazine | S | Antineoplastics, Immunosuppressives and Immunomodulators | Powder for injection: 100 mg in vial; 200mg/; 500mg | p. 13 |
| Dactinomycin | S | Antineoplastics, Immunosuppressives and Immunomodulators | Powder for injection: 500 micrograms in vial | p. 12 |
| Danazol | S | Antineoplastics, Immunosuppressives and Immunomodulators | Capsule 100mg Special for Haematology | p. 13 |
| Dapagliflozin | S | Medicines Used for Diabetes and Related Disorders | Tablet 5mg, 10mg | p. 22 |
| Dapsone | S | Reserve Group Antibiotics | Tablet 50mg, 100 mg (Level A for ant leprosy) | p. 9 |
| Darbepoetin alfa | S | Anti- anaemia Medicines | Vials (Solution for Injection): 25 mcg/Ml; 40 mcg/mL; 60 mcg/mL; 100 mcg/mL; 200 mcg/mL | p. 17 |
| Defibrotide | S | Thrombolytics | Injection: 10 mg/mL | p. 20 |
| Delamanid | S | Reserve Group Antibiotics | Tablet 50 mg | p. 9 |
| Desloratadine | S | Anti-allergies and Medicines Used in Anaphylaxis | Tablet: 5 mg film-coated | p. 5 |
| Desmopressin | S | Posterior Pituitary Hormones and Analogues | Tablets: 0.1 mg, 0.2 mg. Injection: 4 mcg/Ml Nasal Spray: 0.01% (delivers 10 mcg per spray) | p. 16 |
| Dexketoprofen | S | Non-opioids and Non-steroidal Anti-inflammatory Medicines (NSAIMs) | Tablet: 25mg | p. 4 |
| Dexmedetomidine | S | Injectable Medicines and Other Pre-Medication | Injection 100mcg/mL | p. 3 |
| Digoxin Immune Fab-Ovine | S | Medicines Used in Heart Failure | Injection: 40 mg per vial | p. 19 |
| Dobutamine | S | Medicines Used in Heart Failure | Injection 250mg/5mL | p. 19 |
| Docetaxel | S | Antineoplastics, Immunosuppressives and Immunomodulators | Concentrate for infusion 120mg; 80mg | p. 13 |
| Donepezil | S | Medicines used in Psychotic Disorders | Tablet 5mg, 10mg, 23mg | p. 26 |
| Dopamine | D, S | Medicines Used in Heart Failure | Injection 250mg Injection 250mg/mL | p. 19 |
| Dorzolamide | S | Miotics and Antiglaucoma | Drops 20 mg/ml | p. 25 |
| Doxazosin | S | Antihypertensive Medicines | Tablet: 2mg; 4mg | p. 18 |
| Doxorubicin | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 10mg; 20mg, 50mg | p. 13 |
| Duloxetine | S | Medicines used in Depressive disorders | Capsule: 20 mg; 30 mg; 40 mg; 60 mg | p. 27 |
| Dutasteride | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 0.5mg | p. 13 |
| Dydrogesterone | S | Progesterone | 10mg tablet | p. 16 |
| Econazole | S | Anti-infective Agents | Eye Drops 5% | p. 24 |
| Edaravone | S | Medicines used in Psychotic Disorders | Injection: 1.5mg/ml Oral suspension: 105mg/5ml | p. 26 |
| Eflornithine | S | Medicines for Notifiable and Neglected Tropical Diseases | Injection: 200mg/mL | p. 30 |
| Eltrombopag | S | Blood Coagulation Factors | Tablet 25mg | p. 18 |
| Entacapone | S | Ant parkinsonism Medicines and Anti prolactinoma | Tablet 200mg | p. 16 |
| Entecavir | S | Medicines for Hepatitis-B | Tablet: 0.5mg | p. 11 |
| enzalutamide | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablets/Capsule: 40 mg; 80 mg | p. 12 |
| Epirubicin | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 2 mg/mL | p. 13 |
| Eplerenone | S | Diuretics | Tablet 25mg, 50mg | p. 19 |
| Erlotinib | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 25mg, 100mg, 150mg | p. 14 |
| Escitalopram | S | Medicines used in Depressive disorders | Tablet: 5mg, 10mg, 20mg | p. 27 |
| Esmolol | S | Antihypertensive Medicines | Injection: 10g/mL | p. 19 |
| Esomeprazole | S | Antiulcer Medicines | Tablet 20mg; 40mg | p. 21 |
| Estradiol | S | Oestrogens | Tablet 1 mg, 2mg; Injection: 2mg/mL, 10mg/mL | p. 15 |
| Etomidate | S | Injectable Medicines and Other Pre-Medication | Injection 20mg/mL | p. 3 |
| Etoposide | S | Antineoplastics, Immunosuppressives and Immunomodulators | Capsule: 100 mg; Injection 100 mg/mL; Injection 50mg/5mL | p. 13 |
| Etoricoxib | S | Medicines for Treatment of Acute Attack | Tablet: 30 mg; 60 mg; 90 mg; 120 mg | p. 12 |
| Euphobia prostrata extract | S | Anti-Haemorrhoids | Tablet: 100mg, cream: 1% | p. 22 |
| Everolimus | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet 0.25, 0.5mg | p. 13 |
| Febuxostat | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet 40mg; 80mg | p. 13 |
| Fentanyl | S | Opioid Analgesics/Antagonists | Injection 100mcg/2mL; Patches | p. 5 |
| Filgrastim | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 5mcg | p. 13 |
| Finerenone | S | Adrenal Hormones and Synthetic Substitutes | Tablet: 10 mg, 20 mg, and 40 mg. | p. 15 |
| Flucytosine | S | Antifungal Medicines | Isotonic infusion solution containing flucytosine (1%) and 0.805% sodium chloride Tablet 250mg, 500mg | p. 10 |
| Fludarabine | S | Antineoplastics, Immunosuppressives and Immunomodulators | lyophilized powder for Injection: 50mg/2ml Tablet: 10 mg | p. 13 |
| Fluoxetine | S | Medicines used in Depressive disorders | Capsule: 20mg | p. 27 |
| Flupenthixol decanoate | S | Medicines used in Psychotic Disorders | Injection: 20 mg/mL: 100 mg/mL: 200 mg/mL | p. 26 |
| Folinic acid | S | Antipneumocystosis and ant toxoplasmosis medicines | Tablets: 5 mg, 10 mg, 15 mg, and 25 mg Injection: 10 mg/mL, 20 mg/ml. | p. 12 |
| Folinic acid | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablets: 5 mg, 10 mg, 15 mg, and 25 mg Injection: 10 mg/mL, 20 mg/mL. | p. 14 |
| Ganciclovir | S | Other Ocular Preparations | Injection: 50 mg/mL ophthalmic gel: 0.15% | p. 25 |
| Gefitinib | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 250mg | p. 14 |
| Gemcitabine | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 200mg; 500mg; 1000mg | p. 13 |
| Glucagon | S | Medicines Used for Diabetes and Related Disorders | Powder for reconstitution: 10mg/vial | p. 22 |
| Glucosamine + Chondroitin sulphate | S | Vitamins/Minerals | Tablet: 1500 mg +1200 mg | p. 29 |
| Glyceryl trinitrate | C, S | Antianginal Medicines | Spray (sublingual): 400 micrograms/metered dose Tablet (sublingual): 300 micrograms; 400 micrograms; 500 micrograms; 600 micrograms Extended-Release Capsules: 2.5 mg; 6.5 mg; 9 mg Injectable Concentrate: 5 mg/mL | p. 18 |
| Glycopyrrolate | S | Injectable Medicines and Other Pre-Medication | Tablet 1mg, 2mg Injection 200mcg/mL in 1mL, 600mcg in 3mL | p. 3 |
| Goserelin | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection 3.6mg, 10.8mg | p. 14 |
| Heparin | S | Medicines Affecting Coagulation | Gel: 500I.U/gm, 1000 I.U/gm | p. 17 |
| Homatropine | S | Mydriatics and Anti-vascular Endothelial | Drops 2% | p. 25 |
| Human chorionic gonadotrophins | S | Ovulation Inducers | Powder for Injection: 5,000 I.U, 10,000 I. U | p. 15 |
| Human Immunoglobulin G | S | Human Immunoglobulins | Injection; 50mg/ml, 100mg/ml, 200mg/ml | p. 17 |
| Hyaluronic acid | S | Other Ocular Preparations | Injection (intra articular): 16 mg | p. 26 |
| Hydroxychloroquine | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet 200mg | p. 14 |
| Ibandronate | S | Bisphosphonate (Bone resorption inhibitor) | Injection: 3 mg/3ml | p. 31 |
| Ifosfamide | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection 1g/20mL | p. 14 |
| Imatinib | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet 400mg | p. 14 |
| Imipenem + Cilastatin | S | Reserve Group Antibiotics | Powder for injection 500 mg + 500 mg vial | p. 9 |
| Imiquimod | S | Medicines Affecting Skin differentiation and Proliferation | Cream: 2.5%, 3.75%, 5% | p. 21 |
| Immunoglobulin Intravenous (IGIV)) | S | Human Immunoglobulins | Injection: 50 mg/mL; 100 mg/mL | p. 17 |
| Infliximab | S | Drugs affecting Intestinal Secretion and Antispasmodics | Injection 100mg (Special permit) | p. 22 |
| Interferon alfa | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 22,500,000 I.U/1.5ml | p. 14 |
| Interleukin-2 | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 22,000,000 I. U | p. 14 |
| Intraperitoneal dialysis solution | S | Dialysis Solution and Other Related Medicines | Parenteral solution (of appropriate composition) | p. 26 |
| Ipilimumab | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 5mg/ml | p. 15 |
| Ipratropium Bromide Aerosol | S | Anti-asthmatics | Inhalation (aerosol): 20 microgram/metered dose; Nebulizer 250- 500mcg | p. 28 |
| Irbesartan | S | Antihypertensive Medicines | Tablet 150mg, 300mg; Tablet in fixed dose combination | p. 19 |
| Irinotecan | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 180mg/mL | p. 14 |
| Isotretinoin | S | Medicines Affecting Skin differentiation and Proliferation | Cream 0.05%, Capsule 10mg, 20mg | p. 21 |
| Ivabradine | S | Medicines Used in Heart Failure | Tablet: 5mg; 7.5 mg Oral solution: 5 mg/5 mL | p. 19 |
| Ketoprofen | S | Non-opioids and Non-steroidal Anti-inflammatory Medicines (NSAIMs) | Tablet/Capsule: 50mg, 75mg, 200mg; Gel 2.5% w/w | p. 4 |
| L-Ornithine L-Aspartate | S | Cathartics | Granules: 3 gm, 6 gm Injection: 5gm/10ml | p. 22 |
| Lamotrigine | S | Anticonvulsants and Antiepileptics | Tablet: 100mg, 200mg | p. 6 |
| Lamotrigine | S | Medicines in Bipolar Disorders | Tablet 100mg, 200mg | p. 27 |
| Leflunomide | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 10mg; 20mg | p. 13 |
| Lenalidomide | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 25mg | p. 14 |
| Lenvatinib | S | Antineoplastics, Immunosuppressives and Immunomodulators | Capsule: 4 mg; 10 mg. | p. 14 |
| Letrozole | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 2.5 mg. | p. 15 |
| Leuprolide | S | Gonadotropin-Releasing Hormone (GnRH) Analogues / Agonists | Injection 1 mg/mL | p. 16 |
| Levetiracetam | S | Anticonvulsants and Antiepileptics | Injection 5mg/mL, 10mg/mL, 15mg/mL, 100mg/mL, Tablet 250mg, 500mg, 750mg, 1000mg | p. 6 |
| Levofloxacin | S | Reserve Group Antibiotics | Tablet 250 mg | p. 9 |
| Lifitegrast | S | Other Ocular Preparations | Ophthalmic solution: 5% | p. 26 |
| Linezolid | S | Reserve Group Antibiotics | Injection for intravenous administration: 2mg/mL in 300mL bag; Tablet 400mg; 600mg | p. 9 |
| Lipid emulsion | S | Injectable Medicines and Other Pre-Medication | Solution: 20% | p. 3 |
| Liposomal Amphotericin B | S | Antifungal Medicines | Injection 5mg/ml | p. 9 |
| Liposomal Doxorubicin | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 2mg/ml, 5mg/ml | p. 13 |
| Lutropin hormone | S | Ovulation Inducers | Powder for Injection: 75 I. U | p. 15 |
| Magnesium trisilicate | A, S | Antiulcer Medicines | Tablet: (250mg magnesium trisilicate + 120mg dried aluminum hydroxide) Injection 50mcg; 100mcg, 200mcg, 500 mcg | p. 21 |
| Meglumine Antimoniate | S | Medicines for Notifiable and Neglected Tropical Diseases | Injection 1.5mg/5ml in 5ml ampoule | p. 30 |
| Melarsoprol | S | Medicines for Notifiable and Neglected Tropical Diseases | 5% solution (60mg/mL) | p. 30 |
| Memantine | S | Medicines used in Psychotic Disorders | Tablet 5mg, 7mg, 10mg, 14mg, 21mg, 28mg | p. 26 |
| Menotropin (follicle stimulating hormone + | S | Ovulation Inducers | Injection: 75 I.U, 150I.U | p. 15 |
| Meropenem | S | Reserve Group Antibiotics | Injection 500 mg, 1000 mg | p. 9 |
| Mesalazine | S | Non-opioids and Non-steroidal Anti-inflammatory Medicines (NSAIMs) | Tablet: 400mg, 500mg, 800mg | p. 5 |
| Mesna | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 100mg/mL; Tablet 400mg | p. 14 |
| Methionine | S | Antidotes (Specific) | Injection: 15 mg/mL | p. 6 |
| Methotrexate | S | Antineoplastics, Immunosuppressives and Immunomodulators | Concentrated injection: 1000 mg/10 mL. Injection: 50 mg/2 mL. Powder for injection: 50 mg (as sodium) in vial. Tablet: 2.5 mg (as sodium), 10 mg | p. 14 |
| Methylbenzethonium chloride | S | Medicines for Notifiable and Neglected Tropical Diseases | Solution (Topical): 0.1–0.2% | p. 30 |
| Methylphenidate | S | Medicines used in Depressive disorders | Tablet 10mg, 20mg, 30mg, 40mg | p. 27 |
| Metolazone | S | Antihypertensive Medicines | Tablet: 5mg | p. 19 |
| Metoprolol | C, S | Antihypertensive Medicines | Tablet 50mg Injection 1mg/mL | p. 19 |
| Metyrapone | S | Adrenal Hormones and Synthetic Substitutes | Tablet: 250mg | p. 15 |
| Midodrine | S | Antianginal Medicines | Tablet 2.5mg; 5mg; 10mg | p. 18 |
| Milrinone | S | Medicines Used in Heart Failure | Injection 1 mg/mL | p. 19 |
| Miltefosine | S | Medicines for Notifiable and Neglected Tropical Diseases | Capsule 10mg, 50mg | p. 30 |
| Mitomycin C | S | Other Ocular Preparations | 5mg/vial, 10 mg/vial | p. 25 |
| Modafinil | S | Medicines used in Depressive disorders | Tablet: 100 mg; 200 mg | p. 27 |
| Mometasone | S | Anti-inflammatory and Anti-pruritic Medicines | Ointment/Cream: 0.1% (as furoate) | p. 21 |
| Mometasone | S | Nasal Preparations | Nasal spray 50 micrograms/dose (as furoate) | p. 30 |
| Moxifloxacin | S | Reserve Group Antibiotics | Tablet 400mg | p. 9 |
| Moxifloxacin | S | Anti-infective Agents | Eye drops: 0.5% | p. 24 |
| Mycophenolate Mofetil | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet 500mg | p. 14 |
| Mycophenolate Sodium | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 360mg | p. 14 |
| Naltrexone | S | Medicines Used for Disorders due to Psychoactive Substance use | Tablet: 50mg | p. 27 |
| Natamycin | S | Anti-infective Agents | Drops 5% | p. 24 |
| Nicardipine | S | Antihypertensive Medicines | Injection 2.5 mg/mL | p. 19 |
| Nifurtimox | S | Medicines for Notifiable and Neglected Tropical Diseases | Tablet: 120mg | p. 30 |
| Nimodipine | S | Antihypertensive Medicines | Capsule 30mg | p. 19 |
| Nivolumab | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 10mg/mL | p. 15 |
| Norepinephrine | S | Injectable Medicines and Other Pre-Medication | Injection: 1mg/ml,2mg/mL | p. 3 |
| Octreotide | S | Posterior Pituitary Hormones and Analogues | Powder and solvent for prolonged release (LAR), suspension for intramuscular injection 10mg, 20mg, 30mg per vial (Special permission | p. 16 |
| Olanzapine | S | Medicines used in Psychotic Disorders | Tablet 5mg; 10mg | p. 26 |
| Oxaliplatin | S | Antineoplastics, Immunosuppressives and Immunomodulators | Powder for injection: 50mg; 100mg in vial; | p. 14 |
| Oxybutynin | S | Medicines for Overactive Bladder | Tablet: 5mg | p. 26 |
| Paclitaxel | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection 260mg vial | p. 14 |
| Pancreatin | S | Digestive/Pancreatic enzyme preparations | Capsule (modified release): 10 000 lipase units + 8000 amylase units + 600 protease units; 25 000 lipase units + 18 000 amylase units + 1000 protease units. | p. 31 |
| Pazopanib | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet 200mg, 400mg | p. 14 |
| Pegfilgrastim | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 6 mg/0.6 mL | p. 13 |
| Pembrolizumab | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 25mg/ml, 50 mg/ml | p. 15 |
| Pemetrexed | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 25 mg/ml | p. 13 |
| Pertuzumab | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection 30 mg/mL | p. 15 |
| Phenoxybenzamine | S | Medicines Used for Diabetes and Related Disorders | Tablet 10 mg | p. 22 |
| Phenylephrine | S | Injectable Medicines and Other Pre-Medication | Injection: 10mg/mL | p. 3 |
| Physostigmine | S | Muscle Relaxants (Peripherally-Acting) and Cholinesterase Inhibitors | Injection: 0.4 mg/ml; 1 mg/ml | p. 24 |
| Piperacillin + Tazobactam | S | Watch Group Antibiotics | Powder for injection 2 g + 250 mg vial; 4 g + 500 mg vial | p. 8 |
| Pirfenidone | S | Antifibrotic / Respiratory | Tablet: 200mg | p. 28 |
| Pneumococcal polysaccharide vaccine | S | For Immunization | Injection | p. 24 |
| Pralidoxime | S | Antidotes (Specific) | Injection: 600mg | p. 6 |
| Prasugrel | S | Anti- Platelet Medicines | Tablet: 10mg (With special permission) | p. 20 |
| Pretomanid | S | Reserve Group Antibiotics | Tablet 200 mg | p. 9 |
| Procarbazine | S | Antineoplastics, Immunosuppressives and Immunomodulators | Capsule: 50 mg; 100 mg | p. 13 |
| Pyridostigmine | S | Muscle Relaxants (Peripherally-Acting) and Cholinesterase Inhibitors | Injection: 5 mg/mL (bromide) in ampoule or vial. Tablet (scored): 60 mg (bromide). | p. 24 |
| Quetiapine | S | Medicines used in Psychotic Disorders | Tablet: 25 mg; 50 mg; 100 mg; 150 mg; 200 mg; 300 mg; 400 mg | p. 26 |
| Ranibizumab | S | Antineoplastics, Immunosuppressives and Immunomodulators | Solution for Intravitreal injection: 0.3mg, 0.5mg | p. 13 |
| Ranolazine | S | Antianginal Medicines | Tablet: 375 mg; 500 mg; 750 mg; 1000 mg | p. 18 |
| Remifentanil | S | Injectable Medicines and Other Pre-Medication | Powder for injection: 1 mg/2 mL; 2 mg/5 mL; 5 mg/10 mL vial | p. 3 |
| Risperidone | S | Medicines used in Psychotic Disorders | Tablet: 0.25 mg; 1 mg; 2 mg; 6.0 mg | p. 26 |
| Rituximab | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection 375 mg | p. 14 |
| Rivaroxaban | S | Medicines Affecting Coagulation | Tablet 15mg, 20mg | p. 17 |
| Rocuronium | S | Muscle Relaxants and Cholinesterase Inhibitors | Injection 50mg/5mL | p. 4 |
| Rosuvastatin | S | Lipid Lowering Medicines | Tablet: 10mg; 20mg | p. 20 |
| Sacubitril + Valsartan | S | Medicines Used in Heart Failure | Tablet 24/26mg, 49/51mg, 97/103mg | p. 19 |
| Selegiline | S | Ant parkinsonism Medicines and Anti prolactinoma | Tablet 5mg | p. 16 |
| Sertraline | S | Medicines used in Depressive disorders | Tablet: 25mg, 50mg, 100mg | p. 27 |
| Sevelamer | S | Phosphate Binders | Tablet: 400mg, 800mg | p. 29 |
| Sevoflurane | S | Inhalational Medicines | Inhalation | p. 3 |
| Sildenafil | S | Antihypertensive Medicines | Tabet 25mg, 50mg, 100mg | p. 19 |
| Sirolimus | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet 1mg, 2mg | p. 14 |
| Sitagliptin | S | Medicines Used for Diabetes and Related Disorders | Tablet 50mg; 100mg | p. 22 |
| Sodium Hyaluronate | S | Vitamins/Minerals | Injection. 1% | p. 29 |
| Sodium Stibogluconate | S | Medicines for Notifiable and Neglected Tropical Diseases | Injection intralesional: 100mg/mL | p. 30 |
| Sorafenib | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 200mg | p. 14 |
| Sotalol | S | Antiarrhythmic Medicines | Tablet: 80 mg; 120 mg; 160 mg; 240 mg Oral solution 5mg/ml with control Injection: 15mg/mL | p. 18 |
| Streptokinase | S | Thrombolytics | Powder for injection: 1.5 million IU in vial. | p. 20 |
| Sucralfate | S | Non-opioids and Non-steroidal Anti-inflammatory Medicines (NSAIMs) | enemas (rectal preparation): 2g/20ml, 2g/50mls, 2g/100mls, 3g/100mls | p. 5 |
| Sugammadex | S | Muscle Relaxants and Cholinesterase Inhibitors | Injection: 100mg/mL | p. 4 |
| Sugammadex | S | Antidotes (Specific) | Injection 100mg/mL | p. 6 |
| Sumatriptan | S | Medicines for Treatment of Acute Attack | Tablet 25mg, 50mg, 100mg: Injection: 6 mg/0.5 mL; Nasal Spray: 20 mg/0.1 mL | p. 12 |
| sunitinib | S | Antineoplastics, Immunosuppressives and Immunomodulators | Capsule: 12.5 mg, 25 mg, 37.5 mg, and 50 mg | p. 14 |
| Suramin | S | Medicines for Notifiable and Neglected Tropical Diseases | Injection: 100mg/mL | p. 30 |
| Tacrolimus | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 0.5mg; 1mg; 2mg Ointment: 0.1%, 0.03% | p. 15 |
| Tamoxifen | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet 20mg | p. 15 |
| Telmisartan | S | Antihypertensive Medicines | Tablet: 40mg; 80mg; Tablet in fixed dose combination | p. 19 |
| Temozolomide | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet 200mg | p. 15 |
| Tenecteplase | S | Thrombolytics | Injection: 10 mg/mL | p. 20 |
| Thalidomide | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 200mg | p. 15 |
| Ticagrelor | S | Anti- Platelet Medicines | Tablet: 60mg; 90mg (With special permission) | p. 20 |
| Tiotropium | S | Anti-asthmatics | Inhalation1.25mcg/actuation; 2.5mcg/actuation (With special permit) | p. 28 |
| Tizanidine | S | Muscle Relaxants and Cholinesterase Inhibitors | Tablet/Capsule: 2mg; 4mg | p. 4 |
| Tofacitinib | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 5mg, 10mg | p. 14 |
| Tolterodine | S | Medicines for Overactive Bladder | Tablet : 1mg, 2mg, 4mg | p. 26 |
| Tolvaptan | S | Diuretics | Tablets: 7.5mg; 15 mg; 30 mg | p. 20 |
| Torsemide | S | Diuretics | Tablet: 2.5mg, 5mg; 10mg | p. 20 |
| Trametinib | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet: 0.5mg, 1mg, 2mg | p. 14 |
| Trastuzumab | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 440mg; 150mg; 600mg; 500mg | p. 15 |
| Tretinoin | S | Medicines Affecting Skin differentiation and Proliferation | Cream: 2.5% | p. 21 |
| Triamcinolone | C, S | Anti-inflammatory and Anti-pruritic Medicines | Injection 40mg/mL as Acetonide Cream/ointment: 0.1%, 0.5% | p. 21 |
| Ulinastatin | S | Antineoplastics, Immunosuppressives and Immunomodulators | Powder for injection: 100,000 IU vial | p. 15 |
| Ursodeoxycholic acid | S | Drugs affecting Intestinal Secretion and Antispasmodics | Tablet/capsule 300mg | p. 22 |
| Valganciclovir | S | Anti-Herpes Medicines | Tablet 450mg | p. 10 |
| Vancomycin | S | Reserve Group Antibiotics | Capsule 125 mg, 250 mg (as hydrochloride); Powder for injection 250 mg vial | p. 9 |
| Vasopressin | S | Posterior Pituitary Hormones and Analogues | Solution for injection: 20I.U/ml | p. 16 |
| Venetoclax | S | Antineoplastics, Immunosuppressives and Immunomodulators | Tablet 10 mg; 50 mg; 100 mg | p. 15 |
| Venlafaxine | S | Medicines used in Depressive disorders | Tablet: 25mg, 50mg, 75mg, 100mg | p. 27 |
| Verapamil | S | Antiarrhythmic Medicines | Injection: 2.5mg/mL, 2mL ampoule Tablet: 40 mg; 80mg | p. 18 |
| Vinblastine | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 10mg | p. 15 |
| Vincristine | S | Antineoplastics, Immunosuppressives and Immunomodulators | Powder for injection: 2 mg; 5 mg (sulfate) in vial. | p. 15 |
| Vinorelbine | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 10 mg per mL Capsules:20 mg, 30 mg, and 80 mg | p. 14 |
| Xylometazoline | S | Nasal Preparations | Nasal spray: 0.05% | p. 30 |
| Zoledronic acid | S | Antineoplastics, Immunosuppressives and Immunomodulators | Injection: 4mg; 5mg | p. 15 |
| Zoledronic acid | S | Bisphosphonate (Bone resorption inhibitor) | Injection: 4 mg/ 5ml | p. 31 |
| Zolpidem | S | Medicines used in Depressive disorders | Tablet/capsule: 5 mg; 6.25 mg; 7.5 mg; 10 mg; 12.5 mg | p. 27 |
| Zuclopenthixol | S | Medicines used in Psychotic Disorders | Injection: 50mg/mL (Acetate) | p. 26 |
Who can prescribe level S medicines?
Level S medicines may be prescribed by specialists (STG/NEMLIT 7th edition, Part I, Table 1).
| Level | Facility | Who may prescribe |
|---|---|---|
| A | Dispensary | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer, Assistant Clinical Officer |
| B | Health centre | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer |
| C | Council or district hospital | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer |
| D | Regional referral hospital | Specialist, Medical Officer, Dental Officer |
| S (listed) | Zonal, special and national hospitals | Specialist |
New to DukadawaRx? Register as a prescriber. Licensed prescribers only; we verify your registration before you can prescribe.
Source: Standard Treatment Guidelines and National Essential Medicines List (STG/NEMLIT), 7th edition, 2026, Ministry of Health, Part I and the NEMLIT tables.
This page supports licensed prescribers and pharmacists. It is not medical advice and does not replace the Standard Treatment Guidelines, the product information or professional judgement. Prices and stock change often: confirm with the pharmacy.